<DOC>
	<DOCNO>NCT00325650</DOCNO>
	<brief_summary>Primary objective : To evaluate effect long-term administration Rimonabant time progression type 2 diabetes patient prediabetes ( i.e . Impaired Fasting Glucose ( IFG ) Impaired Glucose Tolerance ( IGT ) baseline ) . Secondary objective : - To assess effect weight loss weight maintenance ; sustain effect follow washout period , effect marker glycemic control ( fast glucose , fasting-insulin HbA1c ) , glucose tolerance insulin responses oral glucose tolerance test ( OGTTs ) , risk factor ( HDL-Cholesterol , TG ) , - To assess effect quality life - To evaluate long term safety tolerability .</brief_summary>
	<brief_title>Rimonabant In Prediabetic Subjects To Delay Onset Of Type 2 Diabetes</brief_title>
	<detailed_description>The total duration per patient approximately 38 month include 30-month double-blind treatment period .</detailed_description>
	<mesh_term>Glucose Intolerance</mesh_term>
	<mesh_term>Prediabetic State</mesh_term>
	<mesh_term>Rimonabant</mesh_term>
	<criteria>No previous history treatment type 2 diabetes . Diagnosis : Impaired Glucose Tolerance ( IGT ) base one oral glucose tolerance test ( OGTT ) define 2 hour postchallenge glucose ( 75g Oral Glucose Tolerance Test ) &gt; 140 mg/dL ( 7.8 mmol/L ) &lt; 200 mg/dL ( 11.1 mmol/L ) , screen visit . And / impaired fasting glucose ( IFG ) base Fasting Plasma Glucose ( FPG ) Â³ 100 mg/dL ( 5.6 mmol/L ) &lt; 126 mg/dL ( 7.0 mmol/L ) , screen visit . Absence effective contraceptive method female childbearing potential . Presence clinically significant endocrine disease accord Investigator.Note : euthyroid patient replacement therapy include dosage thyroxine stable least 3 month prior screen visit . Presence severe medical psychological condition chronic conditions/infections opinion Investigator would compromise patient 's safety successful participation study . Presence history cancer within past five year exception adequately treat localized basal cell skin cancer situ uterine cervical cancer . Related laboratory finding : positive test hepatitis B surface antigen and/or hepatitis C antibody ; Positive urine pregnancy test female childbearing potential ; Thyroidstimulating hormone ( TSH ) free T4 outside central laboratory normal range . Related previous concomitant medication : Within 3 month prior screen visit and/or screen period : antiobesity drug ( e.g. , sibutramine , orlistat , herbal preparation , etc ) , systemic longacting corticosteroid ; prolong use ( 10 day ) systemic corticosteroid ;</criteria>
	<gender>All</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>Prediabetic state</keyword>
	<keyword>Impaired fasting glucose</keyword>
	<keyword>Impaired glucose Tolerance</keyword>
</DOC>